New England Private Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
New England Private Wealth Advisors's BMY Position: Q4 2019 in Review
New England Private Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2019, closing a stake of 4,025 shares — an estimated $203K sold.
New England Private Wealth Advisors first reported a position in BMY in Q3 2013 and held it in 22 quarters. The position peaked at $463K in Q2 2016. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.
- New England Private Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2019 after selling out during the quarter.
- New England Private Wealth Advisors sold 4,025 Bristol-Myers Squibb shares in Q4 2019, an estimated $203K.
- New England Private Wealth Advisors first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 22 quarters.
- New England Private Wealth Advisors's Bristol-Myers Squibb position peaked at $463K in Q2 2016.
- 2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.
Based on New England Private Wealth Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.